Patent Applications published on Mar 31, 2022 - page 4

#901
US20220096421A1
Human necessities

Active Ingredient, Pharmaceutical Composition, and Medicinal Product for HIV and AIDS Therapy

#902 ✅ Patent 12,370,167 granted on 2025-07-29
US20220096422A1
Human necessities

BLOOD-BRAIN BARRIER PERMEABILITY REGULATOR AND USE THEREOF

#903
US20220096423A1
Human necessities

Treatment of Bladder Cancer by Local Administration of Taxane Particles

#904 ✅ Patent 12,138,240 granted on 2024-11-12
US20220096424A1
Human necessities

Treatment of cardiac dysfunction

#905 ✅ Patent 11,707,444 granted on 2023-07-25
US20220096425A1
Human necessities

Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient

#906 ✅ Patent 11,819,492 granted on 2023-11-21
US20220096426A1
Human necessities

Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis

#907 ✅ Patent 11,337,954 granted on 2022-05-24
US20220096427A1
Human necessities

Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith

#908 ✅ Patent 12,029,725 granted on 2024-07-09
US20220096428A1
Human necessities

Method for treating osteoarthritis pain by administering resiniferatoxin

#909 ✅ Patent 11,364,221 granted on 2022-06-21
US20220096429A1
Human necessities

MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin or other psychedelics

#910 ✅ Patent 12,161,620 granted on 2024-12-10
US20220096430A1
Human necessities

Devices and methods for facilitating and controlling use of a medication

#911
US20220096431A1
Human necessities

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING, TREATING AND DIAGNOSING A NEURODEGENERATIVE DISEASE

#912
US20220096432A1
Human necessities

METHOD FOR TREATING ZIKA VIRUS INFECTION WITH QUERCETIN-CONTAINING COMPOSITIONS

#913
US20220096433A1
Human necessities

COMPOSITIONS COMPRISING UROLITHINS AND USES THEREOF FOR THE STIMULATION OF INSULIN SECRETION

#914
US20220096434A1
Human necessities

LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS

#915 ✅ Patent 12,226,398 granted on 2025-02-18
US20220096435A1
Human necessities

FABP4 as a therapeutic target in skin diseases

#916
US20220096436A1
Human necessities

COMBINATION PRODUCT FOR THE TREATMENT OF CANCER

#917
US20220096437A1
Human necessities

ANTIBACTERIAL COMPOUNDS

#918
US20220096438A1
Human necessities

METHODS OF TREATING MIGRAINE

#919 ✅ Patent 12,350,256 granted on 2025-07-08
US20220096439A1
Human necessities

Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases

#920 ✅ Patent 11,484,527 granted on 2022-11-01
US20220096440A1
Human necessities

Opioid receptor modulator dosage formulations

#921
US20220096441A1
Human necessities

TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS

#922 ✅ Patent 11,596,623 granted on 2023-03-07
US20220096442A1
Human necessities

Methods for treating virus infection or proliferation

#923
US20220096443A1
Human necessities

PHARMACEUTICAL COMPOSITION

#924
US20220096444A1
Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT FOR DELIRIUM

#925
US20220096445A1
Human necessities

PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING

#926
US20220096446A1
Human necessities

USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER

#927
US20220096447A1
Human necessities

TREATMENT OF RESTENOSIS USING TEMSIROLIMUS

#928 ✅ Patent 12,138,251 granted on 2024-11-12
US20220096448A1
Human necessities

Fibrosis drug

#929
US20220096449A1
Human necessities

METHOD OF TREATMENT WITH TRADIPITANT

#930
US20220096450A1
Human necessities

Compounds and Methods for Treating or Preventing Heart Failure

#931 ✅ Patent 12,290,510 granted on 2025-05-06
US20220096451A1
Human necessities

Polyvalent derivatives of emoxypine

#932
US20220096452A1
Human necessities

LOCAL ANESTHETIC FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS RESULTING FROM BRAIN DYSFUNCTIONS

#933
US20220096453A1
Human necessities

FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR

#934
US20220096454A1
Human necessities

CARBOXYLIC ACID DERIVATIVES

#935
US20220096455A1
Human necessities

USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION

#936 ✅ Patent 11,844,793 granted on 2023-12-19
US20220096456A1
Human necessities

Liquid formulations of indacaterol

#937 ✅ Patent 12,070,456 granted on 2024-08-27
US20220096457A1
Human necessities

Compositions and methods for treating infection

#938
US20220096458A1
Human necessities

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan

#939
US20220096459A1
Human necessities

RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS

#940
US20220096460A1
Human necessities

ABUSE-RESISTANT LONG-ACTING RELEASE OPIOID PRODRUGS

#941
US20220096461A1
Human necessities

LIQUID ORAL DOSAGE FORMULATIONS OF METHYLNALTREXONE

#942 ✅ Patent 11,433,067 granted on 2022-09-06
US20220096462A1
Human necessities

Bupropion as a modulator of drug activity

#943 ✅ Patent 12,076,316 granted on 2024-09-03
US20220096463A1
Human necessities

Levorphanol prodrugs and processes for making and using them

#944
US20220096464A1
Human necessities

METHODS OF TREATING CANCER USING COMPOSITIONS COMPRISING PERILLYL ALCOHOL DERIVATIVE

#945
US20220096465A1
Human necessities

USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY

#946
US20220096466A1
Human necessities

TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MEDIATED BY SENESCENT ASTROCYTES USING SMALL MOLECULE SENOLYTIC AGENTS

#947
US20220096467A1
Human necessities

COMBINATION OF SELECTIVE ALPHA-ADRENERGIC RECEPTOR AGONIST OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF

#948
US20220096468A1
Human necessities

Therapeutic agent for RNA viral infection comprising a combination of pyrazine derivative and compound which increases amount of pyrazine derivative ribose triphosphate in cell

#949
US20220096469A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#950
US20220096470A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION OF LEVOSIMENDAN

#951 ✅ Patent 12,350,269 granted on 2025-07-08
US20220096471A1
Human necessities

CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES

#952 ✅ Patent 11,878,015 granted on 2024-01-23
US20220096472A1
Human necessities

Piperidine-substituted Mnk inhibitors and methods related thereto

#953
US20220096473A1
Human necessities

METHOD FOR TREATING AN ACUTE MYELOID LEUKEMIA

#954
US20220096474A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING MACITENTAN FOR THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

#955
US20220096475A1
Human necessities

METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION

#956 ✅ Patent 11,464,777 granted on 2022-10-11
US20220096476A1
Human necessities

Pharmaceutical composition for the treatment of pulmonary arterial hypertension

#957 ✅ Patent 11,298,356 granted on 2022-04-12
US20220096477A1
Human necessities

Amorphous solid dispersions of dasatinib and uses thereof

#958 ✅ Patent 11,324,745 granted on 2022-05-10
US20220096478A1
Human necessities

Amorphous solid dispersions of dasatinib and uses thereof

#959 ✅ Patent 11,413,290 granted on 2022-08-16
US20220096479A1
Human necessities

Amorphous solid dispersions of dasatinib and uses thereof

#960
US20220096480A1
Human necessities

INDOLE MOLECULES AND USE THEREOF IN THE INHIBITION OF DNA POLYMERASES

#961 ✅ Patent 11,666,575 granted on 2023-06-06
US20220096481A1
Human necessities

Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections

#962
US20220096482A1
Human necessities

COMBINATION THERAPIES

#963 ✅ Patent 11,766,439 granted on 2023-09-26
US20220096483A1
Human necessities

Human papilloma virus as predictor of cancer prognosis

#964
US20220096484A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER BY TARGETING FATP2 AND MYELOID DERIVED SUPPRESSOR CELLS

#965
US20220096485A1
Human necessities

FUNCTIONALIZED PYRANO[2,3-D]PYRIMIDIN-7-ONE DERIVATIVES AND METHODS FOR THEIR PREPARATION AND USE

#966
US20220096486A1
Human necessities

COMPOUNDS FOR USE IN THE TREATMENT OF ADCY5-RELATED DYSKINESIA

#967
US20220096487A1
Human necessities

METHODS FOR TREATING HIV WITH DOLUTEGRAVIR AND LAMIVUDINE

#968 ✅ Patent 11,766,441 granted on 2023-09-26
US20220096488A1
Human necessities

Oral liquid compositions including chlorpromazine

#969 ✅ Patent 11,426,413 granted on 2022-08-30
US20220096489A1
Human necessities

Oral liquid compositions including chlorpromazine

#970
US20220096490A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

#971
US20220096491A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE

#972 ✅ Patent 12,280,065 granted on 2025-04-22
US20220096492A1
Human necessities

Pharmaceutical compounds and therapeutic methods

#973 ✅ Patent 11,833,157 granted on 2023-12-05
US20220096493A1
Human necessities

Precipitation resistant small molecule drug formulations

#974
US20220096494A1
Human necessities

PREVENTION OF PRETERM BIRTH (PTB) BY INHIBITION OF FKBP51

#975
US20220096495A1
Human necessities

TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE

#976
US20220096496A1
Human necessities

AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL

#977 ✅ Patent 11,419,880 granted on 2022-08-23
US20220096497A1
Human necessities

Ursodeoxycholic acid-containing agent for treating or preventing presbyopia

#978
US20220096498A1
Human necessities

INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION

#979 ✅ Patent 12,128,056 granted on 2024-10-29
US20220096499A1
Human necessities

Dietary nutrient compositions

#980 ✅ Patent 11,998,555 granted on 2024-06-04
US20220096500A1
Human necessities

Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same

#981 ✅ Patent 12,109,218 granted on 2024-10-08
US20220096501A1
Human necessities

Compositions of grapiprant and methods for using the same

#982
US20220096502A1
Human necessities

TARGETING HYPOXIC CANCER STEM CELLS (CSCS) WITH DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY

#983
US20220096503A1
Human necessities

COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF

#984
US20220096504A1
Human necessities

METHODS AND COMPOSITIONS COMPRISING A 5HT RECEPTOR AGONIST FOR THE TREATMENT OF PSYCHOLOGICAL, COGNITIVE, BEHAVORIAL, AND/OR MOOD DISORDERS

#985
US20220096505A1
Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#986
US20220096506A1
Human necessities

Method for Enhancing Tyrosinase Inhibitory Activity

#987
US20220096507A1
Human necessities

Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO

#988
US20220096508A1
Human necessities

METHOD OF TREATMENT AND PHARMACEUTICAL DOSAGE FORM

#989
US20220096509A1
Human necessities

Reformulating Hospital Gentamicin to reduce the risk of hearing loss while maintaining antimicrobial activity

#990
US20220096510A1
Human necessities

METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRENT INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE

#991
US20220096511A1
Human necessities

ANTIFUNGAL AGENTS WITH IMPROVED WATER SOLUBILITY

#992
US20220096512A1
Human necessities

WATER-BASED ANTIFUNGAL COMPOSITIONS

#993 ✅ Patent 11,633,415 granted on 2023-04-25
US20220096513A1
Human necessities

Compounds and methods useful for treating or preventing cancers

#994
US20220096514A1
Human necessities

METHODS OF TREATING THYMIDINE KINASE 2 DEFICIENCY BY ADMINISTERING DEOXYCYTIDINE AND DEOXYTHYMIDINE

#995
US20220096515A1
Human necessities

Methods and Formulations for Preventing Neurological or Psychiatric Disorders

#996
US20220096516A1
Human necessities

OLIGONUCLEOTIDE MOLECULE AND APPLICATION THEREOF IN TUMOR THERAPY

#997
US20220096517A1
Human necessities

MicroRNA Compounds and Methods for Modulating MIR-10B Activity

#998
US20220096518A1
Human necessities

COMPOSITIONS AND METHODS FOR CANCER THERAPY

#999
US20220096519A1
Human necessities

SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING SPRAY DRIED VITAMIN B12

#1000
US20220096520A1
Human necessities

MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT

#1001 ✅ Patent 12,246,029 granted on 2025-03-11
US20220096521A1
Human necessities

High purity RNA compositions and methods for preparation thereof

#1002 ✅ Patent 12,233,084 granted on 2025-02-25
US20220096522A1
Human necessities

High purity RNA compositions and methods for preparation thereof

#1003
US20220096523A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

#1004
US20220096524A1
Human necessities

METHODS OF PROMOTING HEALTHY CATCH-UP GROWTH

#1005
US20220096525A1
Human necessities

NUCLEIC ACID THERAPEUTICS FOR GENETIC DISORDERS

#1006
US20220096526A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR DISEASES AND CONDITIONS

#1007
US20220096527A1
Human necessities

PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION

#1008 ✅ Patent 11,446,325 granted on 2022-09-20
US20220096528A1
Human necessities

Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

#1009
US20220096529A1
Human necessities

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN (HPBETACD) FOR USE IN THE TREATMENT OF BREAST CANCER

#1010
US20220096530A1
Human necessities

SAFE BOVINE HEPARIN, PREPARATION METHOD, AND APPLICATION

#1011
US20220096531A1
Human necessities

EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE

#1012 ✅ Patent 11,738,040 granted on 2023-08-29
US20220096532A1
Human necessities

Composition for treating joint disease and kit containing same

#1013
US20220096533A1
Human necessities

LIGNIN SOLVATION USING AQUEOUS BIOLOGICALLY COMPATIBLE BUFFERS

#1014
US20220096534A1
Human necessities

PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION

#1015
US20220096535A1
Human necessities

COMBINATION DRUG THERAPIES OF PDE-5 INHIBITORS AND INHALED NITRIC OXIDE

#1016 ✅ Patent 11,826,382 granted on 2023-11-28
US20220096536A1
Human necessities

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

#1017
US20220096537A1
Human necessities

METHODS FOR TREATING DILATED CARDIOMYOPATHY

#1018
US20220096538A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTION AND/OR TREATMENT OF INFLAMMATION

#1019
US20220096539A1
Human necessities

SALT NANOPARTICLES AND COMPOSITIONS AND METHODS OF USE THEREOF

#1020 ✅ Patent 12,239,663 granted on 2025-03-04
US20220096540A1
Human necessities

Pharmaceutical composition for prevention or treatment of lysosomal storage disorders

#1021
US20220096541A1
Human necessities

METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES

#1022
US20220096542A1
Human necessities

AUGMENTATION OF NATURAL KILLER CELL ACTIVITY AND INDUCTION OF CYTOTOXIC IMMUNITY USING LEUKOCYTE LYSATE ACTIVATED ALLOGENEIC DENDRITIC CELLS: STEMVACS

#1023
US20220096543A1
Human necessities

TOLLIP DEFICIENT NEUTROPHILS AND USES THEREOF

#1024
US20220096544A1
Human necessities

CHEMOKINE EXPRESSING CELL AND USE THEREOF

#1025 ✅ Patent 12,344,658 granted on 2025-07-01
US20220096545A1
Human necessities

NANOPARTICLE FORMULATIONS

#1026
US20220096546A1
Human necessities

Modified Cell Expansion and Uses Thereof

#1027
US20220096547A1
Human necessities

MODIFIED IMMUNE CELLS EXPRESSING FLAGELLIN POLYPEPTIDE

#1028
US20220096548A1
Human necessities

MODIFIED IMMUNE CELLS CO-EXPRESSING CHIMERIC ANTIGEN RECEPTOR AND IL-6 ANTAGONIST FOR REDUCING TOXICITY AND USES THEREOF IN ADOPTIVE CELL THERAPY

#1029
US20220096549A1
Human necessities

CHIMERIC CYTOKINE RECEPTORS

#1030 ✅ Patent 12,234,481 granted on 2025-02-25
US20220096550A1
Human necessities

Use of exosome derived from decidual natural killer (dNK) cells or dNK cell subset in preparation of drug and auxiliary therapeutic agent for infertility-related diseases

#1031
US20220096551A1
Human necessities

COMBINATIONS, NANOPARTICLES AND METHODS FOR CONTROLLING NATURAL KILLER CELL ACTIVATION AND FUNCTION

#1032
US20220096552A1
Human necessities

METHOD AND COMPOSITION FOR PREDICTING LONG-TERM SURVIVAL IN CANCER IMMUNOTHERAPY

#1033 ✅ Patent 12,297,452 granted on 2025-05-13
US20220096553A1
Human necessities

Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells

#1034 ✅ Patent 12,291,574 granted on 2025-05-06
US20220096554A1
Human necessities

Pooled NK cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease

#1035 ✅ Patent 11,364,266 granted on 2022-06-21
US20220096555A1
Human necessities

Restimulation of cryopreserved tumor infiltrating lymphocytes

#1036 ✅ Patent 12,357,659 granted on 2025-07-15
US20220096556A1
Human necessities

PRODUCTION OF MEGAKARYOCYTES OR PLATELETS FROM MONOCYTES

#1037 ✅ Patent 11,590,174 granted on 2023-02-28
US20220096557A1
Human necessities

Method for treating osteoarthritis

#1038
US20220096558A1
Human necessities

SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS

#1039
US20220096559A1
Human necessities

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS

#1040
US20220096560A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES

#1041
US20220096561A1
Human necessities

INHIBITING OR ALLEVIATING AGENT FOR INFLAMMATION IN THE BRAIN

#1042
US20220096562A1
Human necessities

OSTEOBLAST CELL-MIXTURE, AND IMPLEMENTATIONS THEREOF

#1043
US20220096563A1
Human necessities

COMPOSITION FOR TREATING INFLAMMATORY DISEASE INDUCED BY HYPERIMMUNE RESPONSE

#1044
US20220096564A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS

#1045
US20220096565A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#1046
US20220096566A1
Human necessities

THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF DYSBIOSIS

#1047
US20220096567A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING VANCOMYCIN-RESISTANT ENTEROCOCCI INFECTION OR COLONIZATION

#1048
US20220096568A1
Human necessities

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#1049
US20220096569A1
Human necessities

PROBIOTIC SPORTS NUTRITION COMPOSITIONS

#1050 ✅ Patent 11,564,956 granted on 2023-01-31
US20220096570A1
Human necessities

with colorectal cancer inhibition function and use thereof

#1051 ✅ Patent 11,541,085 granted on 2023-01-03
US20220096571A1
Human necessities

Postbiotic extract and preparation process and use thereof

#1052 ✅ Patent 11,517,596 granted on 2022-12-06
US20220096572A1
Human necessities

Method for alleviating arthritis with postbiotic extract

#1053 ✅ Patent 11,517,597 granted on 2022-12-06
US20220096573A1
Human necessities

Method for improving skin condition with postbiotic extract

#1054
US20220096574A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER CONDITIONS CAUSED BY GUT MICROBIAL DYSBIOSIS

#1055 ✅ Patent 11,744,867 granted on 2023-09-05
US20220096575A1
Human necessities

Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and disease

#1056
US20220096576A1
Human necessities

Methods of Identifying Bacteriophages that can Infect and Kill Host-Adapted Pathogenic Bacteria

#1057
US20220096577A1
Human necessities

ONCOLYTIC ADENOVIRUS COMPOSITIONS

#1058
US20220096578A1
Human necessities

COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS

#1059
US20220096579A1
Human necessities

Production and Use of Yeast Extract as a Medical Adjuvant

#1060
US20220096580A1
Human necessities

METHOD FOR STIMULATING GROWTH OF BACTERIA IN THE GUT MICROBIOTA OF A MAMMAL

#1061 ✅ Patent 11,464,818 granted on 2022-10-11
US20220096581A1
Human necessities

Cannabinoids infused consumables

#1062 ✅ Patent 11,464,819 granted on 2022-10-11
US20220096582A1
Human necessities

Cannabinoids infused consumables and non-consumables

#1063 ✅ Patent 11,311,589 granted on 2022-04-26
US20220096583A1
Human necessities

Cannabinoids infused coffee beans and raw nuts

#1064 ✅ Patent 12,311,003 granted on 2025-05-27
US20220096584A1
Human necessities

Cannabinoids infused consumables

#1065 ✅ Patent 11,717,550 granted on 2023-08-08
US20220096585A1
Human necessities

Method for preparing drinking water for livestock to create environment for revitalizing intestinal effective microorganisms using treatment of components via ion exchange of natural minerals

#1066
US20220096586A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A FRACTION OF MELISSA OFFICINALIS LEAF EXTRACT

#1067
US20220096587A1
Human necessities

Compositions and Methods for Treating and Preventing Helicobacter Pylori Infections

#1068 ✅ Patent 12,168,033 granted on 2024-12-17
US20220096588A1
Human necessities

Synergistic composition for osteoarthritis

#1069
US20220096589A1
Human necessities

METHODS OF TREATING CERVICAL CANCER

#1070
US20220096590A1
Human necessities

NOVEL-ANTI-INFECTIVE STRATEGY AGAINST INFLUENZA VIRUS AND S. AUREUS COINFECTIONS

#1071 ✅ Patent 12,251,417 granted on 2025-03-18
US20220096591A1
Human necessities

Antimicrobial compounds from the genus

#1072
US20220096592A1
Human necessities

PIC1 VARIANTS WITH IMPROVED SOLUBILITY AND METHODS OF USING THE SAME

#1073 ✅ Patent 12,178,840 granted on 2024-12-31
US20220096593A1
Human necessities

Method and compositions comprising a CT20 peptide

#1074
US20220096594A1
Human necessities

MACROCYCLIC PEPTIDES FOR TARGETED INHIBITION OF AUTOPHAGY

#1075
US20220096595A1
Human necessities

ANTI-ATOPIC DERMATITIS PROTEIN

#1076
US20220096596A1
Human necessities

METHOD OF TREATING AMD IN PATIENTS REFRACTORY TO ANTI-VEGF THERAPY

#1077
US20220096597A1
Human necessities

CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)

#1078
US20220096598A1
Human necessities

FIBROBLAST GROWTH FACTOR 21 VARIANT, AND FUSION PROTEIN AND USE THEREOF

#1079
US20220096599A1
Human necessities

METHOD FOR PREVENTING, TREATING OR DELAYING MYOCARDIAL DAMAGE USING NEUREGULIN AND COMPOSITION

#1080
US20220096600A1
Human necessities

PERIOSTEAL SKELETAL STEM CELLS IN BONE REPAIR

#1081 ✅ Patent 12,295,986 granted on 2025-05-13
US20220096601A1
Human necessities

Combination immunotherapy for treatment of melanoma, colon or non-small cell lung cancers

#1082
US20220096602A1
Human necessities

LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION

#1083 ✅ Patent 12,178,852 granted on 2024-12-31
US20220096603A1
Human necessities

Insulin formulations and uses in infusion devices

#1084 ✅ Patent 12,109,253 granted on 2024-10-08
US20220096604A1
Human necessities

Use of IGFBP7 for treating malaria

#1085 ✅ Patent 11,938,171 granted on 2024-03-26
US20220096605A1
Human necessities

Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods

#1086
US20220096606A1
Human necessities

Compositions and Methods for Treatment of Duchenne Muscular Dystrophy

#1087
US20220096607A1
Human necessities

SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF

#1088 ✅ Patent 12,226,462 granted on 2025-02-18
US20220096608A1
Human necessities

Fibrinolytic composition and method of its preparation

#1089
US20220096609A1
Human necessities

COMBINATION THERAPY USING CLOSTRIDIAL TOXIN DERIVATIVE AND AT LEAST ONE CHEMICAL DEPOLARIZING AGENT

#1090 ✅ Patent 12,257,293 granted on 2025-03-25
US20220096610A1
Human necessities

Methods of treatment for cervical dystonia

#1091
US20220096611A1
Human necessities

ENZYME COMPOSITIONS AND USE THEREOF FOR WOUND HEALING

#1092
US20220096612A1
Human necessities

METHODS FOR INDUCING IMMUNE TOLERANCE

#1093 ✅ Patent 12,090,196 granted on 2024-09-17
US20220096613A1
Human necessities

Trypanosomal vaccine

#1094
US20220096614A1
Human necessities

PEPTIDE-INDUCED NK CELL ACTIVATION

#1095
US20220096615A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

#1096
US20220096616A1
Human necessities

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

#1097
US20220096617A1
Human necessities

ANTI-MALARIA COMPOSITIONS AND METHODS

#1098 ✅ Patent 11,666,647 granted on 2023-06-06
US20220096618A1
Human necessities

Autotransporter-mediated display of complement receptor ligands by bacterial immunogens

#1099 ✅ Patent 11,723,965 granted on 2023-08-15
US20220096619A1
Human necessities

Glycoconjugation processes and compositions

#1100 ✅ Patent 12,226,472 granted on 2025-02-18
US20220096620A1
Human necessities

Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof

#1101 ✅ Patent 11,583,580 granted on 2023-02-21
US20220096621A1
Human necessities

Heat-resistant H1N1 subtype influenza virus mutant strain, preparation method and application thereof

#1102
US20220096622A1
Human necessities

Compositions and Methods for Inducing Protective Immunity Against Human Immunodeficiency Virus Infection

#1103
US20220096623A9
Human necessities

CORONAVIRUS-TARGETING UNIVERSAL DC CELL VACCINE, AND PREPARATION METHOD AND USE THEREOF

#1104
US20220096624A1
Human necessities

EXTRACELLULAR VESICLES HARBORING A SPIKE PROTEIN, NUCLEIC ACIDS FOR PRODUCING THE SAME, AND METHOD OF IMMUNIZING A SUBJECT AGAINST SARS-CoV-2 USING THE SAME

#1105 ✅ Patent 11,376,335 granted on 2022-07-05
US20220096625A1
Human necessities

RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region

#1106 ✅ Patent 11,541,113 granted on 2023-01-03
US20220096626A1
Human necessities

Human cytomegalovirus vaccine

#1107
US20220096627A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

#1108
US20220096628A1
Human necessities

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

#1109
US20220096629A1
Human necessities

METHODS OF DISEASE ACTIVITY PROFILING FOR PERSONALIZED THERAPY MANAGEMENT

#1110 ✅ Patent 11,660,341 granted on 2023-05-30
US20220096630A1
Human necessities

mRNA combination therapy for the treatment of cancer

#1111
US20220096631A1
Human necessities

ALLOGENEIC TUMOR CELL VACCINE

#1112 ✅ Patent 11,944,681 granted on 2024-04-02
US20220096632A1
Human necessities

HIV-1 neutralizing antibodies and uses thereof

#1113
US20220096633A1
Human necessities

LONG-ACTING PHOTORECEPTOR-BINDING NANOPARTICLES, AND COMPOSITIONS AND METHODS THEREOF

#1114
US20220096634A1
Human necessities

METHOD OF MANIPULATING PHAGES WITHIN THE BODY TO ATTACK INFECTIOUS TARGET CELLS

#1115
US20220096635A1
Human necessities

Liposomal Nanoparticle

#1116 ✅ Patent 11,813,331 granted on 2023-11-14
US20220096636A1
Human necessities

Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation

#1117 ✅ Patent 11,826,428 granted on 2023-11-28
US20220096637A1
Human necessities

Solid solution compositions comprising cannabidiols

#1118 ✅ Patent 11,638,757 granted on 2023-05-02
US20220096638A1
Human necessities

Injectable preparation

#1119
US20220096639A1
Human necessities

THERMOREVERSIBLE COMPOSITIONS FOR ADMINISTRATION OF THERAPEUTIC AGENTS

#1120
US20220096640A1
Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#1121
US20220096641A1
Human necessities

PYRROLOBENZODIAZEPINE DIMER COMPOUND WITH IMPROVED SAFETY AND USE THEREOF

#1122 ✅ Patent 11,744,896 granted on 2023-09-05
US20220096642A1
Human necessities

Compositions, use, and method for CDK2-PROTACs for cancer therapy and hearing loss

#1123
US20220096643A1
Human necessities

Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation

#1124
US20220096644A1
Human necessities

CD44 TARGETED MULTI-ARM CONJUGATE

#1125 ✅ Patent 12,076,409 granted on 2024-09-03
US20220096645A1
Human necessities

Polymer-drug conjugates for combination anticancer therapy

#1126
US20220096646A1
Human necessities

SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF

#1127
US20220096647A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

#1128 ✅ Patent 12,280,124 granted on 2025-04-22
US20220096648A1
Human necessities

Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof

#1129
US20220096649A1
Human necessities

IMMUNOMODULATING POLYNUCLEOTIDE CONJUGATES AND METHODS OF USE

#1130
US20220096650A1
Human necessities

BELANTAMAB MAFODOTIN IN COMBINATION WITH PEMBROLIZUMAB FOR TREATING CANCER

#1131 ✅ Patent 12,268,741 granted on 2025-04-08
US20220096651A1
Human necessities

Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)

#1132
US20220096652A1
Human necessities

ACETAL-BASED CLEAVABLE LINKERS

#1133
US20220096653A1
Human necessities

CONJUGATE COMPRISING LIGAND AND CEACAM5 ANTIBODY FAB FRAGMENT

#1134
US20220096654A1
Human necessities

PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF

#1135
US20220096655A1
Human necessities

PLASMA POLYMER NANOPARTICLES CARRYING AGENTS

#1136
US20220096656A1
Human necessities

NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS

#1137
US20220096657A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF DISEASE

#1138
US20220096658A1
Human necessities

ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY

#1139
US20220096659A1
Human necessities

METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS

#1140
US20220096660A1
Human necessities

METHODS FOR FORMING POLYPLEXES

#1141
US20220096661A1
Human necessities

NANOPARTICLES WITH TUNABLE AFTERGLOW AND COMPOSITIONS AND METHODS THEREOF

#1142 ✅ Patent 12,296,027 granted on 2025-05-13
US20220096662A1
Human necessities

Molecular renal probes for detecting acute kidney injury

#1143 ✅ Patent 12,133,901 granted on 2024-11-05
US20220096663A1
Human necessities

PSMA ligand targeted compounds and uses thereof

#1144
US20220096664A1
Human necessities

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

#1145
US20220096665A1
Human necessities

BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING

#1146
US20220096666A1
Human necessities

ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF

#1147 ✅ Patent 12,285,501 granted on 2025-04-29
US20220096667A1
Human necessities

Compound targeting norepinephrine transporter

#1148 ✅ Patent 12,357,711 granted on 2025-07-15
US20220096668A1
Human necessities

PSMA BINDING DUAL MODE RADIOTRACER AND THERAPEUTIC

#1149
US20220096669A1
Human necessities

SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF

#1150 ✅ Patent 12,251,479 granted on 2025-03-18
US20220096670A1
Human necessities

Portable and wearable disinfecting pouch

#1151 ✅ Patent 11,511,004 granted on 2022-11-29
US20220096671A1
Human necessities

Toilet equipped with infrared generator

#1152 ✅ Patent 11,964,063 granted on 2024-04-23
US20220096672A1
Human necessities

Towel disinfection dryer

#1153
US20220096673A1
Human necessities

TOWEL DISINFECTING AND DRYING MACHINE

#1154
US20220096674A1
Human necessities

STERILIZATION CASE

#1155 ✅ Patent 11,896,728 granted on 2024-02-13
US20220096675A1
Human necessities

Techniques for directing ultraviolet energy towards a moving surface

#1156 ✅ Patent 12,115,269 granted on 2024-10-15
US20220096676A1
Human necessities

Techniques for directing ultraviolet energy towards a moving surface

#1157 ✅ Patent 11,957,804 granted on 2024-04-16
US20220096677A1
Human necessities

Optical disinfection systems having side-emitting optical fiber coupled to high-energy UV-C laser diode

#1158
US20220096678A1
Human necessities

DEVICE FOR DISINFECTING AT LEAST ONE OBJECT

#1159 ✅ Patent 12,280,164 granted on 2025-04-22
US20220096679A1
Human necessities

Flashlamp cartridge for decontamination and decontamination unit

#1160
US20220096680A1
Human necessities

SYSTEMS AND METHODS OF UV CLEANING

#1161 ✅ Patent 11,850,319 granted on 2023-12-26
US20220096681A1
Human necessities

Techniques for directing ultraviolet energy towards a moving surface

#1162
US20220096682A1
Human necessities

VEHICLE IGNITION INTERLOCK DECONTAMINATION AND CALIBRATION STATION

#1163 ✅ Patent 12,128,148 granted on 2024-10-29
US20220096683A1
Human necessities

Bimodal ultraviolet disinfection systems and related methods

#1164
US20220096684A1
Human necessities

VEHICLE HAVING DISINFECTION SYSTEM

#1165 ✅ Patent 11,524,087 granted on 2022-12-13
US20220096685A1
Human necessities

Microwave assisted methods and systems for surface decontamination

#1166
US20220096686A1
Human necessities

Pathogen Inactivation by Exposure to a Noble Gas

#1167
US20220096687A1
Human necessities

Sanitizer Aerosol Dispensing Apparatus

#1168 ✅ Patent 11,992,571 granted on 2024-05-28
US20220096688A1
Human necessities

Pens/pencils sanitizing machine

#1169 ✅ Patent 12,171,895 granted on 2024-12-24
US20220096689A1
Human necessities

Portable sterilization and disinfection apparatus for sterilizing and disinfecting space

#1170
US20220096690A1
Human necessities

Aura Disinfecting Machine

#1171 ✅ Patent 11,850,321 granted on 2023-12-26
US20220096691A1
Human necessities

Casing and manufacturing method thereof

#1172
US20220096692A1
Human necessities

OZONE, UVC LIGHT AND STEAM SANITIZER WITH ULTRASONIC NEBULIZER

#1173
US20220096693A1
Human necessities

ENCLOSED SPACE ULTRAVIOLET DISINFECTION SYSTEMS AND RELATED METHODS

#1174 ✅ Patent 12,102,728 granted on 2024-10-01
US20220096694A1
Human necessities

Electronic device with antibacterial effect detection and portable device

#1175
US20220096695A1
Human necessities

COMPOSITION FOR DIFFUSING VOLATILE SUBSTANCES

#1176
US20220096696A1
Human necessities

Device For Disinfecting Air By Means Of Combustion

#1177
US20220096697A1
Human necessities

SYSTEM FOR SCENTING ROOMS

#1178
US20220096698A1
Human necessities

Systems and Methods for Atomizing Liquids

#1179
US20220096699A1
Human necessities

SANITIZING DEVICE WITH PATHOGEN DETECTION, SANITIZING SYSTEM WITH PATHOGEN DETECTION, AND METHODS FOR USE THEREOF

#1180
US20220096700A1
Human necessities

DEVICE THAT USES ULTRAVIOLET LIGHT TO PURIFY AIR

#1181 ✅ Patent 11,511,013 granted on 2022-11-29
US20220096701A1
Human necessities

Air purification and disinfection apparatus and methods of use

#1182 ✅ Patent 11,679,176 granted on 2023-06-20
US20220096702A1
Human necessities

Method and system for LED based virus and bacteria removal

#1183 ✅ Patent 11,779,677 granted on 2023-10-10
US20220096703A1
Human necessities

Photocatalytic oxidation centrifugal fan

#1184 ✅ Patent 11,878,083 granted on 2024-01-23
US20220096704A1
Human necessities

Fibres, a process for producing such fibres and a wound dressing incorporating them

#1185
US20220096705A1
Human necessities

VACUUM MEMBRANE THERMOFORMED POLY-4-HYDROXYBUTYRATE MEDICAL IMPLANTS

#1186
US20220096706A1
Human necessities

ELECTROSPUN NANOFIBER-BASED DRESSINGS AND METHODS OF MANUFACTURE AND USE THEREOF

#1187
US20220096707A1
Human necessities

HEMOSTATIC MATERIAL

#1188 ✅ Patent 11,998,656 granted on 2024-06-04
US20220096708A1
Human necessities

Hemostatic compositions and methods of making thereof

#1189
US20220096709A1
Human necessities

WOUND HEALING THERAPEUTIC HYDROGELS

#1190 ✅ Patent 11,826,489 granted on 2023-11-28
US20220096710A1
Human necessities

Collagen scaffolds

#1191
US20220096711A1
Human necessities

METHOD OF FACILITATING NERVE GROWTH

#1192
US20220096712A1
Human necessities

BIOMATERIALS COMPRISING A SCAFFOLD CONTAINING A MINERAL COMPOUND, AND USES THEREOF AS BONE SUBSTITUTES

#1193
US20220096713A1
Human necessities

SINGLE CONDUIT HEART VALVE WITH UNITARY LEAFLET AND SKIRT

#1194
US20220096714A1
Human necessities

BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS IN BIOCOMPATIBLE MATRIX, AND TREATMENTS THEREOF

#1195
US20220096715A1
Human necessities

STRUCTURED GELS

#1196
US20220096716A1
Human necessities

MEDICAL IMPLANTS INCLUDING LAMINATES OF POLY-4-HYDROXYBUTYRATE AND COPOLYMERS THEREOF

#1197
US20220096717A1
Human necessities

AXITINIB-LOADED NANOFIBER MEMBRANE, PREPARATION METHOD FOR THE SAME, AND ITS USE OF ANTI-ADHESION AFTER A SURGERY

#1198 ✅ Patent 11,752,244 granted on 2023-09-12
US20220096718A1
Human necessities

Blood circuit assembly for a hemodialysis system

#1199 ✅ Patent 12,121,640 granted on 2024-10-22
US20220096719A1
Human necessities

Apparatus for extracorporeal blood treatment

#1200
US20220096720A1
Human necessities

APPARATUS FOR AN EXTRACORPOREAL BLOOD TREATMENT